Latest viral hepatitis mapping report released
COVID-19 Vaccine FAQs - Hepatitis and Liver Disease
Australia’s supply of COVID-19 vaccines is now being rolled out in stages across the country.…Read Article
Help fight viral hepatitis: Call for stories
Five common liver cancer myths
In honour of World Cancer Day on the 4th of February, Hepatitis Queensland is busting…Read Article
The full report provides updated estimates broken down by geographic area including state, territory, PHN and Statistical Area 3 level and identifies priority areas for response.
This year the report contains newly revised region-specific estimates of chronic hepatitis B (CHB) prevalence in Aboriginal and Torres Strait Islander Australians, and adjusted chronic hepatitis C (CHC) prevalence and treatment uptake to account for people currently in correctional facilities. Also new this year is the inclusion of liver cancer incidence data with comparisons to CHB and CHC prevalence and other risk factors at a PHN level.
This report forms the baseline for assessing Australia’s progress towards meeting the targets set out in the Third National Hepatitis B Strategy and Fifth National Hepatitis C Strategy, which cover the period 2018-2022 and set out clear indicators for progress towards eliminating the impact of viral hepatitis.